Phase 3: Steady State Weeks 25-36 Weight loss continues but slows
Cagrilintide Dosing: Clinical Trial Evidence Understanding cagrilintide dosage protocols requires examining the extensive clinical trial data that has emerged from Novo Nordisk's development program
When Will I See Results from Wegovy
The pen is configured as a dial-a-dose device with selectable steps of 0.25mg, 0.5mg, 0.75mg, 1mg or 2mg of each API per injection, giving a total peptide range of 0.54mg per shot [7]
Wegovy: The Weight Management Solution Wegovy is also a once-weekly injectable semaglutide, but it is FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, Type 2 diabetes, or high cholesterol), and in adolescents aged 12 years and older with obesity
Avoid lying down immediately after eating, as this can worsen nausea and increase the likelihood of vomiting